{"id":808590,"date":"2022-07-20T19:14:11","date_gmt":"2022-07-20T17:14:11","guid":{"rendered":"https:\/\/15.161.165.86\/non-categorizzato\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/"},"modified":"2022-07-20T19:14:11","modified_gmt":"2022-07-20T17:14:11","slug":"bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/","title":{"rendered":"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies"},"content":{"rendered":"Capital will advance BigHat\u2019s internal pipeline of therapeutics to patients, expand platform capacity 10-fold, and accelerate strategic partnerships\n\nSAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today announced it has raised a $75 million Series B funding round, led by Section 32, with participation from new investors Amgen Ventures, Bristol Myers Squibb, Quadrille Capital, Gaingels, GRIDS Capital, among others. The investment brings BigHat\u2019s total funding to date to $100 million. Prior investors Andreessen Horowitz, 8VC, and AME Cloud Ventures also contributed to this round, which will be use<div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Capital will advance BigHat\u2019s internal pipeline of therapeutics to patients, expand platform capacity 10-fold, and accelerate strategic partnerships SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today announced it has raised a $75 million Series B funding round, led by Section [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-808590","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BeBeez\" \/>\n<meta property=\"og:description\" content=\"Capital will advance BigHat\u2019s internal pipeline of therapeutics to patients, expand platform capacity 10-fold, and accelerate strategic partnerships SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today announced it has raised a $75 million Series B funding round, led by Section [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-20T17:14:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies\",\"datePublished\":\"2022-07-20T17:14:11+00:00\",\"dateModified\":\"2022-07-20T17:14:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\"},\"wordCount\":1223,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\",\"name\":\"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-07-20T17:14:11+00:00\",\"dateModified\":\"2022-07-20T17:14:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/","og_locale":"en_US","og_type":"article","og_title":"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BeBeez","og_description":"Capital will advance BigHat\u2019s internal pipeline of therapeutics to patients, expand platform capacity 10-fold, and accelerate strategic partnerships SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today announced it has raised a $75 million Series B funding round, led by Section [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/","og_site_name":"BeBeez","article_published_time":"2022-07-20T17:14:11+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/"},"author":{"name":"","@id":""},"headline":"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies","datePublished":"2022-07-20T17:14:11+00:00","dateModified":"2022-07-20T17:14:11+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/"},"wordCount":1223,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/","name":"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-07-20T17:14:11+00:00","dateModified":"2022-07-20T17:14:11+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/808590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=808590"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/808590\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=808590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=808590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=808590"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=808590"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=808590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}